Ligand validation:4UTF

IFM: 5-HYDROXYMETHYL-3,4-DIHYDROXYPIPERIDINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UTF_IFM_A_501	97%	40%	0.062	0.979	0.84	1.48	-	2	0	0	100%	1
6ZJ6_IFM_AAA_407	99%	37%	0.05	0.984	1.5	0.99	1	-	1	0	100%	1
4AD2_IFM_A_501	93%	32%	0.077	0.973	0.99	1.69	-	1	1	0	100%	1
4V27_IFM_A_501	82%	43%	0.115	0.971	0.8	1.39	-	1	1	0	100%	1
4AD4_IFM_A_501	65%	42%	0.126	0.928	0.85	1.37	1	1	2	0	100%	1
4IIC_IFM_B_950	100%	13%	0.027	0.992	2.69	1.29	3	2	0	0	100%	1
4D4D_IFM_B_400	99%	24%	0.046	0.983	0.96	2.13	-	1	0	0	100%	1
1OCN_IFM_A_452	99%	28%	0.05	0.987	0.97	1.91	-	3	0	0	100%	1
1OCQ_IFM_A_500	97%	48%	0.066	0.983	1.05	0.98	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.